A randomized, non-inferiority trial of the serum containing three herbal mixtures versus 5% topical minoxidil solution in the treatment of early stage of male androgenetic alopecia and female pattern hair loss

Chanat Kumtornrut0 个研究点目标入组 160 人开始时间: 2024年8月10日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Male and female patients diagnosed with androgenic alopecia.
•2. Aged 18-65 years.
•3. The stages of androgenic alopecia in males, according to the revised Hamilton's classification, are at levels II, III, III vertex, or IV. The stages of androgenic alopecia in females, according to the Savin scale, are at levels I-2, I-3, I-4, or II-1.

•1. Participants with other hair or scalp diseases, such as seborrheic dermatitis, scalp psoriasis, scalp fungal infections, telogen effluvium, or scarring alopecia.
•2. Participants with medical conditions or chronic illnesses that cause hair loss, such as cancer, anemia, thyroid hormone abnormalities, immunodeficiency, or connective tissue diseases.
•3. Participants who have undergone hair transplant surgery.
•4. Participants who need to use androgen hormones or anti-androgen medications, such as spironolactone, or use hormonal medications for contraception or hormone regulation.
•5. Participants who are pregnant or breastfeeding.
•6. Participants with a history of allergy to minoxidil or any other components in the topical minoxidil solution.

发起方

Chanat Kumtornrut